Solventum Corp reported 1.18B in Gross Profit on Sales for its fiscal quarter ending in June of 2025.


Gross Profit On Sales Change Date
Abbott USD 5.87B 50M Jun/2025
Align Technology USD 708.12M 28.01M Jun/2025
Baxter International USD 1.14B 283M Jun/2025
Becton, Dickinson and Co. USD 2.63B 377M Jun/2025
Cencora USD 2.91B 370.08M Jun/2025
Dexcom USD 688.8M 99.8M Jun/2025
Insulet USD 452.2M 43.2M Jun/2025
Solventum Corp 1.18B 51M Jun/2025
West Pharmaceutical Services USD 273.9M 42M Jun/2025
Zimmer Biomet Holdings USD 1.32B 34.8M Jun/2025